1 January 2007   
News
Executive Vice President's Message
2007 CLSI Leadership Conference and Facing the Challenge: Practical Approaches to Evaluate Analytical Performance Workshop
Development of Global Standards for Antimicrobial Susceptibility Testing: The ISO Initiative
New Quality Management System, The Key to Quality, Scheduled for Release January 2007
Press Releases
Standards Status
Vote and Deadlines
Recently Approved Documents
Events and Exhibits
Upcoming Events
CLSI Meetings Calendar
Participate in CLSI
Volunteer
New and Sustaining Members
Update Your Subscription
 
CLSI Home Page
Search Past Issues
Update Your Contact Information
Print this article Print all articles
 
 
 
Winner of the Silver Award for Patient Education in the WWW Health Awards Program
 
Press Releases

Managing and Validating Laboratory Information Systems (AUTO8-A); Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement (M100-S17)

CLSI Publishes Guideline for Managing and Validating Laboratory Information Systems
Wayne, Pennsylvania, USA—January 2007—The laboratory industry is quickly moving into the era of electronic reports, transmission of information via the Internet, etc., and there is a need to develop guidelines that can provide consistency in the industry. Clinical and Laboratory Standards Institute (CLSI, formerly NCCLS) has recently published a new document, Managing and Validating Laboratory Information Systems; Approved Guideline (AUTO8-A), to provide necessary guidance for developing a protocol for validation of the laboratory information system (LIS), as well as protocols for assessing the dependability of the LIS when storing, retrieving, and transmitting data.
Read full press release.
 
CLSI Publishes New Antimicrobial Susceptibility Testing Standard
Wayne, Pennsylvania, USA—January 2007—CLSI has recently published the annual update of the well-known antimicrobial susceptibility testing standard, Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement (M100-S17), which provides updates of the latest recommendations for detecting emerging resistance of aerobic bacteria—arranged in tabular format. The “breakpoints” included in the supplement are defined as specific values on the basis of which bacteria can be assigned to the clinical categories of susceptible, intermediate, or resistant. This essential information assists clinicians with drug selection, interpretation, and quality control using the procedures standardized in CLSI documents Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Ninth Edition (M2-A9); and Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Seventh Edition (M7-A7).
Read full press release. [ return to top ]

For more information or to contact us directly, please visit www.clsi.org
©2007 Clinical and Laboratory Standards Institute